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Abstract. Myristylation of FBR v-los, a c-los retroviral 
homologue that causes osteosarcomas in mice, deter- 
mines many of its transcriptional properties in vitro. To 
determine whether myristylation of FBR v-los contrib- 
utes to in vivo tumorigenicity, we examined its trans- 
forming capability in comparison to a nonmyristylated 
FBR v-los (G2A-R). Retroviral infections with FBR 
v-fos and G2A-R transform BALB/c-3T3 cells. The 
number, size, and cellular morphology of foci gener- 
ated by both FBR and G2A-R are indistinguishable. 
However, marked biological differences were found 
in transgenic mice expressing either the myristylated 
FBR v-los or the nonmyristylated G2A-R. 11 of 26 
FBR v-los transgenic mice died as a result of gross tu- 
mor burden. None of the 28 G2A-R transgenic mice 
died from tumor burden, and only two of the G2A-R 
mice developed bone tumors. Histologic examination 
of the tumors reveals that the FBR v-fos bone tumors 
contain malignant cells with features of four cell lin- 
eages (osteocytes, chondrocytes, myocytes, and adipo- 
cytes) in an environment rich in extracellular matrix 
(ECM). However, the G2A-R tumors exist in an envi- 
ronment devoid of ECM and display malignant cells 
with features of adipocytes. Masson staining reveals 
that the ECM of the FBR tumors stains strongly for 
collagen. Immunohistochemical staining with collagen 
III antibody demonstrates an abundance of collagen III 
expression in this ECM. While NH2-terminal myristyla- 
tion is not required for FBR immortalization and trans- 
formation, it is essential in determining the degree of 
differentiation and tumorigenicity of malignant cells. 
T 
HE Finkel-Biskis-Reilly mouse osteosarcoma virus 
(FBR-MuSV) 1 was originally isolated from a radia- 
tion induced bone tumor in an XG/f mouse (Finkel 
et al.,  1975). FBR v-fos causes chondro-osseous sarcomas 
when injected into newborn mice (Ward and Young, 1976; 
Lee et al., 1979; Michiels et al., 1984; Silbermann et al., 
1987).  FBR v-los integration into the host chromosome 
and constitutive expression following infection (Van Bev- 
eren et al.,  1984; Meijlink et al.,  1985) leads to the trans- 
formed phenotype observed in established murine fibro- 
blasts as well as in nonestablished mouse connective tissue 
cells (Jenuwein et al., 1985; Jenuwein and Mtiller, 1987). 
FBR v-los is expressed as a 75-kD nuclear protein that 
differs from c-Fos by deletion and replacement  of both 
NH2- and COOH-terminal regions with retroviral gag and 
mouse  fox sequences,  respectively  (Curran  and  Verma, 
1984;  Van  Beveren  et  al.,  1984; Wilson  and  Treisman, 
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MuSV, Finkel-Biskis-Reilly mouse osteosarcoma virus. 
1988).  FBR v-fos represents  an important model in the 
study of carcinogenesis, since its cellular analogue (c-Fos) 
is a transcriptional regulator whose early expression is im- 
plicated in cellular growth and differentiation. Previously 
we have shown that FBR v-fos demonstrates both losses of 
function (inability to transactivate from AP-1 sites and in- 
ability to repress from the serum response element in the 
c-los promoter) and gains of function (transcriptional acti- 
vation of the collagen III promoter) when compared to 
c-Fos (Kamata et. al., 1991; Kamata and Holt, 1992; Jotte 
et al., 1994). The expression of collagen III, which is nor- 
mally tightly controlled during the differentiation of 3T3- 
L1 adipocytes, is markedly disrupted by the presence of 
FBR  v-los  (Jotte  et  al.,  1994).  These  altered  transcrip- 
tional  properties  of FBR  v-fos  are  dependent  upon  its 
myristylated NH2-terminal glycine. A nonmyristylated  point 
mutant FBR protein, G2A-R (for glycine to alanine at the 
second  amino  acid  site),  not  only regains  its  ability to 
transactivate from AP-1 sites and repress at the serum re- 
sponse element, but it also loses its ability to disrupt the 
differentiation-dependent expression of collagen III. Ab- 
sence of myristylation therefore restores FBR's molecular 
mechanisms  to  that  of its  normal  cellular  homologue, 
c-Fos. 
While myristylation is essential for the differentiation- 
dependent transcriptional properties of FBR in vitro, its 
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genesis remain undefined. To address the biological rele- 
vance of FBR v-fos myristylation, we examined FBR and 
G2A-R's ability to transform mouse fibroblasts in tissue 
culture. Myristylation's contribution to tumorigenicity was 
further characterized in vivo in transgenic mice expressing 
either the myristylated or nonmyristylated FBR proteins. 
Materials and Methods 
Cell Cultures and Transfections 
FBR v-fos 3T3-L1 stable cell lines and BALB/c-3T3 cells were grown in 
DME supplemented with 10% FCS (Sigma Chemical Co., St. Louis, MO), 
2 mM L-glutamine (Sigma Chemical Co.), and 1x antibiotic/antimycotic 
(Sigma Chemical Co.). Bosc 23 cells were maintained in DME containing 
10% dialyzed FCS, 0.25 mg/ml xanthine (Sigma Chemical Co.), 2 i~g/ml 
aminopterin (Sigma Chemical Co.), 6 i~g/ml thymidine (Sigma Chemical 
Co.), 25 I~g/ml mycophenolic acid (GIBCO BRL, Gaithersburg, MD), 2 
mM L-glutamine, and lx  antibiotic/antimycotic. 3T3-L1 cells were trans- 
fected as proliferating fibroblasts at 30%  confluency. Cells were trans- 
fected with 10 I~g of MuSV-FBR expression vector and I  Ixg of RSV-neo- 
mycin resistance gene by  the calcium phosphate-DNA coprecipitation 
with glycerol shock (Graham and van der Eb, 1973). After glycerol shock, 
cells were refed in DME with 10% FCS. 24 h later, transfected cells were 
split 1:10 and replenished in DME with 10% FCS and 100 I.~g/ml G418. 
Cells were maintained in tissue culture in the presence of G418 for 3 wk at 
which time colonies were isolated and screened for FBR v-fos expression 
by Western blot. 
Generation of FBR and G2A-R Transient Supernatants 
G2A-R viral  vector was  generated  by  inserting the  NcoI  fragment of 
MuSV LTR-driven G2A-R (Kamata and Holt, 1992) into FBR v-fos. 20 I~g 
of FBR or G2A-R was transiently transfected into Bosc 23 cells (plated at 
a density of 5 ×  105 cells the day before) by the calcium phosphate copre- 
cipitation method. 12 h after transfection, media (DME with 10% FCS) 
was replaced. 48 h after transfection, viral supernatant was harvested and 
spun at 3,000 rpm to remove cellular debris. Viral supernatants were stored 
at -70°C. 
Titering of FBR and G2A-R Viral Supernatants 
For titering by viral RNA hybridization, 20 ml of media in which the viral- 
producing Bosc 23 cells were growing was centrifuged at 4°C at 10,000 
rpm to pellet any producer cells. Supernatants were transferred to a SW27 
polyallomer tube and spun for 2 h  at 27,000 rpm at 4°C. Viral particles 
were resuspended in 0.5 ml of 10 mM Tris-HCl, pH 7.5. Viral suspensions 
were layered onto a 4-ml step gradient in SW50.1 tubes consisting of 2 ml 
25% sucrose in 100 mM Tris-HC1, pH 7.5,  1 ml 40% sucrose in 100 mM 
Tris-HC1, pH 7.5, and I m150% sucrose in 100 mM Tris-HC1, pH 7.5. Viral 
suspensions were centrifuged 3 h at 35,000 rpm at 4°C. Viruses resting at 
the 40%  sucrose cushion were  phenol-chloroform extracted twice  and 
once with chloroform. RNA was precipitated with an equal volume of iso- 
propanol. Precipitated RNA was resuspended in 250 Ixl of 15% formalde- 
hyde and 250 td of 20x SSC. Suspended RNA was heated at 50°C for 15 
min and transferred to an ice bath. Serial dilutions in 10x  SSC of each 
sample were made and adsorbed onto a  Gene Screen Plus membrane 
(Dupont/NEN, Wilmington, DE) through a dot blot minifold apparatus. 
Blots were rinsed in 2x SSC and allowed to air dry. Blots were then baked 
at 80°C for 2 h  to reverse the formaldehyde reaction.  RNA transcripts 
were hybridized with T7 RNA polymerase generated antisense FBR v-fos 
coding sequence at 60°C and washed according to the protocol provided 
by the Gene Screen Plus manufacturers. 
FBR and G2A-R Transformation  Assays in 
BALB/c-3T3 Cells 
2  X l0  s BALB/c-3T3 cells were plated per 10-cm dish the day before in- 
fection.  Serially  diluted  viral supernatants (10  1,  10-2,  10-3,  10-4,  and 
10  -5) were added to BALB/c-3T3 cells in the presence of 6 Ixg/ml poly- 
brene. The following day, plates were split 1 to 10 and allowed to grow in 
DME,  10%  FCS  with  a  media change every 3  d.  At 3  wk, cells were 
stained with Giemsa stain and scored for loci formation. Foci >5 mm in 
diameter were scored as positive. 
Establishment of Transgenic Mouse Lines 
The DNAs injected were the BamHI-XhoI fragment of either the FBR or 
G2A-R expression vectors that encompassed the Moloney Leukemia vi- 
rus LTR and the oncogenic region extending through the polyadenylation 
site (Van Beveren, 1984).  Transgenic mice were established through the 
Vanderbilt University Cancer Center Transgenic Mouse Core. C57BL6 x 
DBA F1 fertilized eggs were injected with either MuSV-LTR driven FBR 
or G2A-R encoding DNA (Hogan et al., 1986).  At 2 wk of age, mice had 
0.5 in of their tails resected and placed into 300 ILl of buffer containing 50 
mM Tris, pH 8.0, 100 mM EDTA, 100 mM NaC1, 1% SDS, and 175 g pro- 
teinase K  (Boehringer Mannheim Corp., Indianapolis, IN). Tails were 
incubated for 12 h  at 55°C and then extracted with an equal volume of 
phenol and chloroform. Precipitated DNA was spooled and resuspended 
into sterile distilled H20. Transmission of the FBR and G2A-R genes in 
founder and progeny mice was confirmed by PCR analysis of mouse tail 
DNA using 5'-CAGAGCGGGAATGGTGAAGA-3' and 5'-TGATGC- 
CGGAAACAAGAAGT-3' oligonucleotides as PCR primers. Founder 
mice were crossed with C57BL6 nontransgenic mice to determine germ- 
line transmission, and progeny mice were screened by PCR as described 
above. 
Tumor Detection, Histology, 
and Immunohistochemistry 
Tumors were initially detected roentgenographically on a  General Elec- 
tric MSI.1250 IV Radiographic Imager (Milwaukee, WI) at settings of 1.5 
kV and 1.5 mA. Tumors were resected from the transgenic mice and im- 
mersed in 3.7% formaldehyde. Tumors were then embedded in low melt- 
ing point Ameraffin (Baxter, Marietta, GA) and sectioned at 4-5 i~m on a 
Reichert-Jung microtome. Processing was conducted according to stan- 
dard procedure by the Vanderbilt  University Medical Center Research 
Management Service.  Standard  Mayers hematoxylin (Fisher  Scientific, 
Pittsburgh,  PA)  and  pholxine  B/eosin  y  (Fisher  Scientific),  Masson 
trichrome  (Fisher  Scientific),  and  Sudan  black  B  (Chroma-Gesellschaft, 
Germany) stains were conducted on paraffin-embedded sections. Immu- 
nohistochemistry was conducted on an automated stainer (model Tech- 
mate; Biotech Res. Labs, Inc., Rockville, MD) using a universal ABC de- 
tection  kit  with DAB  chromagen using the following antibodies: actin 
prediluted monoclonal antibody (Enzo Biochem Inc., New York), cyto- 
keratin cam 5.2 monoclonal antibody (Becton-Dickinson Immunocytome- 
try Sys., Mountain View, CA) diluted 1:20, desmin monoclonal antibody 
(Dako Corp., Corpinteria, CA) diluted 1:500,  and a  rabbit  anti-rat col- 
lagen type III antibody (Pasteur Institute, Lyon, France) diluted 1:20. 
Tumor RNA Isolation and Reverse Transcriptase PCR 
RNA was purified from resected  tumor tissue as previously described 
(Chirgwin et al., 1979).  Tumors were resected and quick-frozen in liquid 
Nz. 10 ml of 4 M guanidinium isothiocyanate, 50 mM Tris, 10 mM EDTA 
solution was added per gram of tissue, and tissue was ground with a tis- 
suemizer. Suspensions were centrifuged 10 min at 10,000 rpm at 12°C, and 
supernatants were heated to 65°C for 2 min in the presence of 2% Sarko- 
syl. CsCI was then added at a concentration of 0.1 g/ml solution and lay- 
ered over 5 ml of 5.7 M CsCI in a SW-28 polyallomer tube. Samples were 
spun overnight at 25,000 rpm at 22°C. RNA pellets were resuspended in 
5 mM EDTA, 0.5% Sarkosyl, and 5% 2-mercaptoethanol. Samples were 
extracted with equal volumes of phenol/chloroformhsoamyl alcohol and 
precipitated.  Quantity and quality of RNA was determined by spectro- 
photometric ultraviolet light absorbance at 260 nm and by ethidium bro- 
mide staining for ribosomal RNA within the total RNA samples. 5 ~g to- 
tal RNA from each sample was treated with 5 U  RNAse-free DNAse I 
(Promega Corp.,  Madison, WI)  at  37°C for  30 min. Samples were  ex- 
tracted with an equal volume of phenol and chloroform and ethanol pre- 
cipitated. RT-PCR was performed by our published methods (Thompson 
et al., 1995) using the following basic method: RNA samples were reverse 
transcribed for 1 h at 37°C using 2 ixg of total RNA, 1 p.g random hexam- 
ers (Boehringer Mannheim Corp.), 1 x  first strand buffer (GIBCO BRL), 
0.01 M DTT, 0.5 mM each dATP, dCTP, dGTP, and dTTP and 200 U Su- 
perscript  II  RNaseH-reverse transcriptase  (GIBCO  BRL).  The  RNA/ 
DNA duplexes were used as templates for 20-cycle PCR reactions using 
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Formation in BALB/c-3T3 Cells 
10  -4 Dilution  10  3  Dilution  10  -2 Dilution 
FBR  43  420  4134 
G2A-R  46  445  4578 
FBR and G2A-R retroviruses were generated as described in Materials and Methods. 
Dilutions were made from the retroviral stocks, l0  6 logarithmically growing BALB/c- 
3T3 cells were infected with 1 ml of the respective dilutions in the presence of poly- 
brene. 12 h after infection, plates were passaged l:10 and allowed to grow for 3 wk. 
Colony foci were scored as positive if colony diameter was >/2 ram. Numbers indicate 
the number of viral particles per ml of initial infecting dilution and represent the aver- 
age of three separate infections. 
Figure 1.  Schematic  diagram  comparing  c-Fos, FBR  v-los,  and 
G2A-R  proteins. FBR v-fos differs from c-Fos by both NH2- and 
COOH-terminal  deletions. These deleted regions are replaced by 
in-frame Moloney murine sarcoma virus gag  and mouse fox se- 
quences, respectively. FBR v-los also contains two in-frame dele- 
tions of 39 and 27 base pairs, which results in two deletions of 13 
and 9  amino acids, respectively, at the COOH  terminus. G2A-R 
differs from FBR  in that a  single base pair change (G to C) con- 
verts the NH2-terminal glycine (essential for myristylation) to an 
alanine. 
the following conditions: denaturation 94°C,  20 s; annealing 52°C, 45  s; 
elongation 75°C, 90 s. FBR and G2A-R specific sequences were amplified 
by PCR with 5'-TrGCCACCCTGCCATGCTAATAA-3'  and 5'-CCAC- 
CGACCTGCCTGCAAGAT-3' primers. These PCR primers detect RNA 
transcripts spanning the los and fox regions of the gene that are specific 
for the viral oncogene, 2534 to 2719 from the published sequence (Van 
Beveren et al., 1984). 20% of PCR products were run on a 2% agarose gel 
and visualized with ethidium bromide intercalation and UV lighting. 
Results 
Transformation by FBR is Myristylation Independent 
To address the biological relevance of FBR v-los myristy- 
lation, retroviral vectors encoding myristylated FBR v-los 
and non-myristylated G2A-R (Fig.  1) were generated as 
described in Materials and Methods. The FBR v-los and 
G2A-R retroviral vectors were transiently transfected into 
Bosc 23 cells (which harbor the Moloney-murine leukemia 
helper  virus)  by  the  calcium  phosphate  coprecipitation 
method (Graham and van der Eb, 1973). Viral superna- 
tants were harvested and stored at -70°C. Viral RNA was 
Figure 2.  Transformation  assay 
by  FBR  and  G2A-R  retrovi- 
ruses  in  BALB/c-3T3  fibro- 
blasts.  106 logarithmically grow- 
ing  BALB/c-3T3  cells  were 
infected with 103 retrovirus par- 
ticles. 12 h  after infection, plates 
were passaged 1 to 10 and main- 
tained in tissue culture for 3 wk. 
(A and B) Giemsa stain of gross 
FBR  and  G2A-R  transformed 
colonies, respectively. (C and D) 
Cellular  morphology  of  FBR 
and  G2A-R  transformed  colo- 
nies,  respectively.  TC,  trans- 
formed colony. M, BALB/c-3T3 
monolayer.  200  magnification. 
Bar, 20 Ixm. 
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Figure 3.  FBR and G2A-R transgenic mouse survival. 26 FBR 
v-los and 28 G2A-R transgenic mice were generated as described 
in Materials and Methods. Over the course of 20 mo, 11 of the 26 
FBR transgenic mice succumbed to tumor burden and died (a 
58%  tumor-dependent mortality). Of the 28  G2A-R transgenic 
mice, only two developed tumors. These mice were sacrificed at 9 
and 20 mo for tumor histology studies. The first G2A-R mouse 
death was secondary to pneumonia at 4 mo of age. This death and 
the  two  mice  sacrificed for  tissue  examination  were  the  only 
G2A-R transgenic deaths (a 4% study mortality). Dotted  line, the 
average age and standard error of 7.3  --_ 1.2 mo at which FBR 
transgenic mice succumbed to tumor burden. 
purified from these viral supernatants as described in Ma- 
terials  and  Methods,  applied  to  nylon  membranes,  and 
subjected to hybridization with an antisense FBR radiola- 
beled probe capable of hybridizing with RNA  generated 
from both the FBR v-los and G2A-R viral vectors (data 
not  shown).  An  equal  number  of  either  FBR  v-fos  or 
G2A-R serially diluted virus particles (as determined  by 
the viral RNA assay) were used to infect 5  x  105 BALB/c- 
3T3  cells. Cells were  infected with  104, 103, or  102  virus 
particles of either FBR v-fos or G2A-R in the presence of 
polybrene to enhance viral adherence to the plasma mem- 
brane.  12  h  after infection,  BALB/c-3T3  cells were  pas- 
saged at a 1:10 dilution and maintained in tissue culture for 
up to 3  wk. At 3  wk, media was aspirated and the plates 
were  stained  with  Giemsa.  Infection  with  myristylated 
FBR v-fos as well as nonmyristylated G2A-R retrovirus 
causes transformation of BALB/c-3T3 cells as determined 
by foci formation (Fig. 2, A  and B). The growth and size of 
transformed colonies between the two retroviruses are in- 
distinct, and the  cellular morphology of the  transformed 
BALB/c-3T3 cells generated by both retroviruses are also 
very similar (Fig. 2, C  and D). An average of three sepa- 
rate  loci  transformation  assays  reveals  that  the  number 
and size of BALB/c-3T3 loci generated by both FBR and 
G2A-R are indistinguishable (Table I). These experiments 
demonstrate that FBR and G2A-R retroviruses have func- 
tionally indistinct qualitative and  quantitative  transform- 
ing characteristics, indicating that  myristylation of FBR 
v-fos does not affect either its ability or efficiency to cause 
transformation  of  fibroblasts.  Although  the  gross  mor- 
phology of the cells transformed by either the myristylated 
or nonmyristylated forms appears similar, it is conceivable 
that a more detailed structural analysis might reveal differ- 
ences which would correlate with the observed in vivo ef- 
fects. Prior studies have shown no differences in the actin 
cytoskeleton  of these  cells  using  immunohistochemistry, 
but more subtle structural effects may be present. 
Nonmyristylated FBR (G2A-R) Does Not Cause 
Malignant Tumor Growth 
To further  address myristylation's possible role in FBR's 
Figure  4.  Roentgenographic 
examination of transgenic tu- 
mors.  (A) Control C57/BL6 
mouse  x-ray.  Figure  repre- 
sents a normal x-ray of a 6-mo- 
old  non-transgenic  mouse. 
(B)  FBR  v-fos  transgenic 
mouse  x-ray.  Transgenic 
mice were  anesthetized  and 
visualized on a General Elec- 
tric  MSI.1250  IV  Radio- 
graphic  Imager  on  settings 
of 1.5  kV  and  1.5  mA.  Ar- 
rows  indicate  three  sites  of 
FBR  tumor  formation.  (C) 
G2A-R  transgenic  mouse 
x-ray. Transgenic mice were 
anesthetized  and  visualized 
as described in B. Arrows in- 
dicate two sites of G2A-R tu- 
mor formation. 
The Journal of Cell Biology, Volume 135, 1996  460 tumorigenic properties, transgenic mice carrying either the 
myristylated FBR or the non-myristylated G2A-R genes 
were  generated  as  described  in  Material  and  Methods. 
Carriers of the transgene were confirmed by PCR analysis 
of DNA isolated from a resected portion of each mouse's 
tail. PCR analysis was designed to detect both the endoge- 
nous c-los gene as well as the exogenous transgene (data 
not shown). Two FBR and three G2A-R founders were 
generated from the initial transgenic injections. However, 
only one FBR and two G2A-R mice from these founders 
displayed germ-line transmission  of the respective trans- 
genes.  These  founders  were  mated  with  nontransgenic 
B6D2 mice, and F2 progeny were screened for the pres- 
ence of the transgene by PCR analysis (data not shown). 
26 mice harboring the myristylated FBR gene and 28 mice 
carrying the nonmyristylated G2A-R gene were sired from 
the  corresponding  founders  and  compared  for  tumor 
growth and mouse survival. 
Marked  differences  were  observed between  the  FBR 
and  G2A-R transgenics.  Of 26 FBR transgenic mice,  11 
developed tumors and died over the course of 20 mo. Each 
of these  deaths  were secondary to tumor burden.  How- 
ever, of 28 G2A-R transgenic mice, only three died over 
the same time period. The first G2A-R transgenic mouse 
death occurred at 3 mo of age and was due to pneumonia; 
no tumors were detected at autopsy. The two remaining 
deaths were sacrifices at 9 and 20 mo to examine tumor 
histology. More importantly, the two G2A-R mice sacri- 
ficed for tumor histology were the only two G2A-R trans- 
genic mice that developed tumors. While 11% of the G2A-R 
mice died during this study, there was only a 4% mortality 
rate which is attributed to a pneumonia. 0% of the G2A-R 
transgenic mouse deaths were due to tumor burden. How- 
ever, 58% of the FBR transgenics died, all of which were 
deaths caused by tumor burden (Fig. 3). Although the data 
presented was obtained with  a  single line of FBR trans- 
genic mice, a second founder (female) developed a  large 
pelvic osteosarcoma which may have contributed to her 
lack of offspring and proved ultimately fatal. This second 
founder confirms that FBR v-los transgenics develop le- 
thal osteosarcomas. 
FBR-  and  G2A-R-induced  tumors  were  initially  de- 
tected roentgenographically as early as 2 mo of age. Fig. 4 A 
demonstrates  a  normal  roentgenogram  from  a  control 
nontransgenic mouse. In comparing the FBR and G2A-R 
tumors,  the  malignant  nature  of the  FBR  tumors  com- 
pared to that of the G2A-R tumors is readily visible (com- 
pare Fig. 4, B  and C). Tumors became grossly detectable 
as early as 3 mo of age with an average survival of 7.3  ___ 
1.2 mo in the FBR transgenic mouse group. 
To ensure that the tumors isolated from the FBR and 
G2A-R transgenics did express the respective transgenes, 
reverse  transcriptase  polymerase chain reactions specific 
for FBR  and  G2A-R sequences  were  conducted.  Total 
RNA was isolated  from the  different tumors by cesium 
chloride purification as described in Materials and Meth- 
ods and digested with RNAse-free DNAse to ensure sam- 
ples were not contaminated with DNA. Primers were de- 
signed to encompass FBR and G2A-R specific sequences 
which flank the fos/fox junction in FBR and G2A-R. Be- 
cause the  amplified region lies  near the  3'  end  of FBR, 
only completely transcribed  message  is  detected.  Fig.  5 
Figure 5.  Reverse transcriptase  PCR of FBR and G2A-R tran- 
scripts isolated from tumors. Reverse transcriptase PCR was per- 
formed on total RNA isolated from FBR and G2A-R resected 
tumors. Equal levels of RNAs were confirmed by spectrophoto- 
metric ultraviolet light absorption  at 260 nm and by ribosomal 
staining with ethidium bromide.  Samples without reverse  tran- 
scriptase served as a negative control to ensure that amplified se- 
quences were driven from an RNA template and not DNA. Total 
RNA isolated from FBR and G2A-R stably transfected 3T3-L1 
cell lines served  as positive controls. Amplified PCR products 
were resolved on a 2%  agarose gel and visualized by ethidium 
bromide  staining. (Lane  1)  100-bp molecular weight standards 
(Promega). (Lane 2) FBR stably transfected 3T3-L1 cell line neg- 
ative control, no reverse transcriptase. (Lane 3) FBR stably trans- 
fected 3T3-L1 cell line positive control. (Lane 4) G2A-R stably 
transfected  3T3-L1 cell line negative  control,  no reverse  tran- 
scriptase.  (Lane  5)  G2A-R stably transfected  3T3-L1 cell line 
positive control. (Lane 6) FBR tumor RNA negative control, no 
reverse transcriptase. (Lane 7) FBR tumor RNA generated PCR 
product.  (Lane 8) G2A-R tumor RNA negative control, no re- 
verse transcriptase. (Lane 9) G2A-R tumor RNA generated PCR 
product. (Lane 10) Same as Lane 1. 
demonstrates that both the FBR-induced tumors and the 
G2A-R induced tumors express message for their respec- 
tive genes (Fig. 5, lanes 7 and 9). Total RNA isolated from 
3T3-L1 cell lines stably transfected with the FBR or G2A-R 
genes served as positive controls (Fig.  5, lanes 3  and 5). 
Omission of the reverse transcriptase cDNA step served 
as  a  negative control to ensure that amplified fragments 
were  not  generated  from  contaminating  DNA  (Fig.  5, 
lanes 2, 4, 6, and 8). This study confirms that the FBR and 
G2A-R tumors express messages encoded by the respec- 
tive transgenes. 
Myristylation of FBR Defines Tumor Histology 
Subsequent to the deaths of the FBR transgenic mice, tu- 
Jotte and Holt  Myristylation-dependent  FBR Tumor  Differentiation  461 Figure 6.  Haematoxylin and eosin stains of FBR and G2A-R tumor sections.  (A) Control mouse long bone. Femur was isolated from a 
nontransgenic C57BL6 mouse, fixed, and stained as described in Materials and Methods. O, osteocytes within calcified  bone; C, chon- 
drocytes within cartilage; BM, bone marrow. (B) Central FBR tumor section. FBR tumors were resected, fixed, and stained as described 
in Materials and Methods. This section represents a central portion typical of the FBR tumors with osteosarcomatous features (O) 
within calcified bone and discrete regions of soft tissue consisting of poorly differentiated mesenchymal cells (M). (C) Peripheral FBR 
tumor section. This is a peripheral section demonstrating the fibrous capsule (FC) which surrounds FBR tumors. A soft tissue compo- 
nent is seen just inside the fibrous capsule and is rich in extracellular matrix (ECM). (D) G2A-R tumor section. This figure is represen- 
tative of the cellular histology seen throughout the majority of the G2A-R tumors. The tumors are very cellular,  representing trans- 
formed cells of the adipocyte lineage (AD), and devoid of the extracellular matrix seen in FBR tumors. A-D 100 magnification. (E) 
Control mouse long bone at high power. Higher magnification of control long bone seen in A demonstrates the normal cellular histology 
consisting of chondrocytes (C), osteocytes (O), and bone marrow (BM). (F) Central portion of FBR tumor at high power. This section 
demonstrates the cellular pattern typical of osteosarcoma (O), chondrosarcoma (C), and poorly differentiated mesenchymal cells (ME) 
seen in FBR tumors. (G) Peripheral section of FBR tumor at high power. This figure reveals the histologic pattern of cells typically seen 
at the periphery and within the extracellular matrix of FBR tumors. MY, myosarcomatous cells; ME, poorly differentiated mesenchymal 
cells. (H) G2A-R tumor at high power magnification. This section reveals the poorly differentiated mesenchymal cells (ME) and cells 
representative of the adipocyte-like liposarcomas (AD). Arrows point to areas of lipid-laden cells (L1). E-H 400 magnification. Bars: 
(A-D) 40 Ixm; (E-H) 10 ~m. 
mors  were  excised  and  compared  with  tumors  isolated 
from the sacrificed G2A-R transgenics.  Tumors and nor- 
mal long bone were fixed in 3.7%  formaldehyde, paraffin 
embedded,  and sectioned for histologic examination.  Fig. 
6, A  and  E,  is  haematoxylin  and  eosin  stains  of normal 
long bone for comparison.  H&E staining of FBR tumor 
sections reveals that these tumors are osteosarcomas (Fig. 
6  B)  with  additional  features  of chondrosarcoma,  rhab- 
domyosarcoma, and liposarcoma. FBR tumors also pos- 
sess a peripheral band of fibrous tissue which encapsulates 
the tumor (Fig. 6  C). High power views reveal the multi- 
ple  differentiated  features  of  the  FBR  osteosarcomas 
throughout the tumor (Fig.  6, F  and  G).  G2A-R tumors, 
however,  are  liposarcomas  and  lack features  of multiple 
differentiated cell lineages other than the adipocyte (Fig. 6 
D).  Although  the  G2A-R  liposarcomas  possess  a  large 
proportion  of  poorly  differentiated  mesenchymal  cells, 
there are adipocyte-like cells with lipid-laden vesicles (Fig. 
6  H).  Sudan black staining for lipid  and phospholipid  re- 
veals  that  FBR  tumors  express  low  levels  of lipid,  and 
G2A-R tumors express significant levels (Fig. 7, A  and D). 
Immunohistologic stains for actin reveals that FBR tumors 
stain positive in regions consistent with rhabdomyosarco- 
matous  features  (compare  Fig.  7,  B  and  C).  However, 
G2A-R  tumors  do  not  stain  for  actin,  confirming  that 
G2A-R  tumors  lack  cells  with  myocyte-type  features 
(compare Fig, 7, E  and F). Additional stains for cytokera- 
tin  were  conducted  to  determine  if  either  the  FBR  or 
G2A-R tumors  contain cells  of epithelial  origin.  Neither 
FBR  or  G2A-R  tumors  stain  positively  for  cytokeratin 
(data  not  shown).  Thus,  FBR  tumors  display  character- 
istics  with  four  differentiating  features  (osteosarcoma, 
chondrosarcoma,  rhabdomyosarcoma,  and  liposarcoma). 
However, G2A-R tumors only display features of the dif- 
ferentiating liposarcoma. 
Closer  examination  of the  FBR osteosarcomas reveals 
an abundance  of extracellular  matrix  (ECM)  throughout 
the  tumor  (Fig.  8  A).  G2A-R  liposarcomas  display  a 
largely cellular component that is devoid of the ECM seen 
in FBR tumors  (Fig.  8 D).  Masson staining of the tumor 
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ing in FBR and  G2A-R tu- 
mors.  (A)  Sudan  black  B 
stain of FBR tumor. FBR tu- 
mors  were  fixed, sectioned, 
and  stained  as  described  in 
Materials  and  Methods. 
Sudan  black  B  detects  cells 
of the adipocyte lineage, as it 
stains lipids and phospholip- 
ids  black. The  arrow  indi- 
cates a poorly differentiated 
mesenchymal cell that  stains 
positively for Sudan black B. 
(B) FBR control  actin stain. 
Section represents  the back- 
ground  immunoperoxidase 
staining pattern  observed  in 
FBR  tumor  sections. This 
field  represents  the  periph- 
ery of the FBR tumor within 
the  extracellular matrix. Ar- 
rows indicate myocytes (MY) 
visible in this portion  of the 
FBR tumor. (C) Actin stain- 
ing seen in FBR tumors. Ar- 
rows point  to  actin  positive 
staining, which is seen within 
cells  noted  to  be  myocytes 
(MY).  (D)  Sudan  black  B 
stain of G2A-R tumor. G2A-R 
tumors were fixed, sectioned, 
and stained as described in Materials and Methods. Note the overall increased staining for Sudan black B throughout  the tumor, con- 
firming the adipocyte-like features of the G2A-R liposarcomas. Arrows indicate lipid-laden liposarcoma cells. (E) G2A-R control actin 
stain. Section represents  the background immunoperoxidase staining pattern  observed in G2A-R tumor sections. (F) Actin staining 
seen in G2A-R tumors. Note the lack of positive staining throughout the G2A-R tumor section, confirming the absence of cells from the 
myocyte lineage in G2A-R tumors. 400 magnification. Bar, 10 p,m. 
sections reveals that the high levels of ECM seen in FBR 
tumors stain strongly for collagen (Fig. 8 B). FBR osteosar- 
comas also contain a fibrous capsule that encompasses the 
tumor and is rich in collagen (Fig. 8 C, arrows). G2A-R tu- 
mors not only lack this fibrous capsule, but they also fail to 
stain for collagen throughout the tumor (Fig. 8 E). These 
studies demonstrate that the FBR tumors that are rich in 
ECM express high levels of collagen protein, whereas the 
G2A-R tumors lack ECM and therefore fail to stain for 
collagen. 
Because FBR is known to transcriptionally activate the 
collagen III promoter (Setoyama et al., 1986a; Jotte et al., 
1994), specific immunoperoxidase staining for collagen III 
was  performed on  the  FBR  and  G2A-R tumors  as  de- 
scribed  in  Materials  and  Methods.  Immunoperoxidase 
positive staining was greatest at the periphery of the FBR 
tumors within the fibrous capsule (compare Fig. 9, A  and 
B). This suggests that the fibrous capsule surrounding the 
FBR osteosarcomas consists  largely of collagen III pro- 
tein. Higher magnification reveals the extent of ECM-rich 
FBR osteosarcoma which stains  for collagen III protein 
(compare Fig. 9, C and D). G2A-R liposarcomas demon- 
strate a markedly lower level of collagen III protein ex- 
pression throughout the tumor (compare Fig. 9, G and H). 
There is also a lack of enhanced collagen III expression at 
the tumor periphery, as the G2A-R liposarcomas lack a fi- 
brous capsule (compare Fig. 9, E and F). 
Discussion 
These data demonstrate that while myristylation of a viral 
oncogene is  independent of its ability to transform and 
immortalize cells in tissue culture, its role in vivo is crucial 
for tumorigenesis. Myristylated FBR-induced tumors are 
osteosarcomas  with  features  of  chondrosarcoma,  rhab- 
domyosarcoma, and  fibrosarcoma.  The  nonmyristylated 
mutant  G2A-R  induced  tumors  are  liposarcomas.  The 
presence of the myristoyl moiety on FBR protein allows 
malignant mesenchymal cells to enter and disrupt multiple 
differentiation pathways leading to tumors with features 
of osteosarcomas, chondrosarcomas, rhabdomyosarcomas, 
and liposarcomas. But nonmyristylated FBR disrupts the 
differentiation of a single cell lineage leading to liposarco- 
mas.  The differentiation  pattern  of osteocytes, chondro- 
cytes, and myocytes are not disrupted  and therefore ap- 
pear normal in the G2A-R transgenic mice. Although we 
do not detect the level of lipid-accumulating adipocytes in 
the  FBR osteosarcomas as  in  the  G2A-R liposarcomas, 
there are a high number of fibroblasts and primitive mes- 
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tracellular  matrix present in 
FBR tumors, but not G2A-R 
tumors.  (A)  Extracellular 
matrix  component  of  FBR 
tumors. H&E stain  of FBR 
tumor section  reveals ECM 
within the soft tissue compo- 
nent of FBR tumors. Arrows 
mark whorling  pattern char- 
acteristic  of  collagen  fibrils 
typically found in ECM.  400 
magnification.  (B)  Masson 
trichrome  stain  of FBR  tu- 
mor. FBR tumors were fixed, 
sectioned,  and stained  as de- 
scribed  in  Materials  and 
Methods.  Masson  trichrome 
stains nuclei black, cytoplasm 
red, and collagen fibrils blue. 
Note the  abundance  of col- 
lagen staining throughout the 
extracellular  matrix  (ECM). 
400 magnification.  (C) Mas- 
son trichrome  stain  at FBR 
tumor  periphery.  This  sec- 
tion  reveals  the  increased 
collagen  staining  observed 
within  the  fibrous  capsule 
(FC) at the periphery of FBR 
tumors.  Dark arrows demar- 
cate  the  border of collagen 
expression  in  the  FBR  tu- 
mor  capsule.  White  arrow 
notes  the  presence of myo- 
cytes (MY) within the tumor capsule. 400 magnification.  (D) G2A-R tumor devoid of ECM. H&E stain demonstrates the absence of 
ECM throughout the highly cellular G2A-R liposarcoma.  Compare this with the ECM seen in FBR tumors in Fig. 8 A. 400 magnifica- 
tion.  (E) Masson trichrome stain of G2A-R tumor. G2A-R tumors were fixed, sectioned,  and stained  as described  in Materials  and 
Methods.  Note the absence of collagen staining within the G2A-R liposarcomas.  Red staining is reflective  of the abundance of cyto- 
plasm within the highly cellular G2A-R tumors. 400 magnification. Bars: (A, B, D, and E) 10 p~m;  (C) 20 ixm. 
enchymal cells (Fig.  6  G), which  have also been seen in 
FBR retrovirus-induced tumors (Price et al., 1972; Finkel 
et al., 1975; Ward and Young, 1976).  These primitive mes- 
enchymal  cells  may  represent  preadipocytes  which  are 
blocked from entering the adipocyte differentiation path- 
way (Fig. 10). FBR v-los transformed tumor cells also exist 
in an extracellular matrix rich in collagen III that is tran- 
scriptionally  activated  by  FBR  v-los  (Setoyama  et  al., 
1986a, b; Jotte et al., 1994). Such an environment may alter 
programmed cellular differentiation and allow FBR trans- 
formed ceils to disrupt multiple differentiation pathways 
(Liau et al., 1985; Yoakum et al., 1985; Coppola and Cole, 
1986). 
The indistinguishable efficacy by which FBR and G2A-R 
cause immortalization indicates  that  myristylation is  not 
necessary for cellular transformation to occur.  Other re- 
gions within the FBR protein must be responsible for this 
initial  step  toward  tumorigenicity.  Fos  sequences  within 
FBR are a  likely candidate for its immortalizing features, 
as unregulated expression of Fos has been shown to over- 
come the limited proliferative capacity of different cell lin- 
eages causing transformation (Jenuwein and Mtiller, 1987; 
Lassar et al., 1989). Although Fos sequences may initiate 
tumorigenesis by causing cellular transformation, these se- 
quences are not the sole determinant of the differentiation 
pathways followed by the  transformed cells.  This is evi- 
denced by the different predominant lineages observed in 
the FBR and G2A-R tumors. Myristylation of FBR pro- 
tein  defines  which  differentiation  pathways  will  be  dis- 
rupted. Thus, it would appear that the parameters which 
dictate cellular growth and immortalization are dependent 
upon  Fos  sequences,  and  the  differentiation  patterns  of 
FBR transformed cells are dependent upon myristylation. 
The  mechanisms  by  which  FBR  and  nonmyristylated 
G2A-R transformed cells disrupt  differentiation  remains 
unknown. Perhaps myristylation of FBR endows it with a 
novel  transcriptional  activity or  function  which  disrupts 
the differentiation pathway of various cell lineages. Previ- 
ous work in our lab and other's has examined FBR's myri- 
stylation-dependent transcriptional activity of the collagen 
III gene (Setoyama et al., 1986a, b; Jotte et al., 1994).  Col- 
lagen  III expression  is  markedly down-regulated  during 
the differentiation of adipocytes (Weiner et al., 1989; Jotte 
et al.,  1994).  Collagen III's expression is shut  off by day 
two of 3T3-L1 adipocyte differentiation (Jotte et al., 1994). 
3T3-L1  cells stably transfected with FBR  demonstrate  a 
disruption of this expression pattern, whereas G2A-R sta- 
bly  transfected  3T3-L1  cells  demonstrate  a  normal  col- 
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sion in FBR and G2A-R tumors. 
(A)  FBR  control  collagen  III 
stain  at  tumor periphery. FBR 
tumors  were  fixed,  sectioned, 
and stained  as described  in Ma- 
terials  and  Methods.  Collagen 
III  positive  staining  is  repre- 
sented  by  an  immunoperoxi- 
dase  generated  brown  color. 
Section  represents  the  back- 
ground staining  pattern for the 
collagen  III antibody observed 
in FBR tumor sections at the fi- 
brous  capsule  (FC).  (B)  Col- 
lagen III staining seen in the pe- 
riphery of FBR tumors. Arrows 
demarcate  the  border  of  col- 
lagen Ill expression  within  the 
fibrous capsule  (FC). Also note 
the overall increase in general- 
ized  staining  for  collagen  III 
throughout  the  tumor  section. 
(C)  FBR  control  collagen  III 
stain  at  higher  magnification. 
Section  represents  the  back- 
ground  immunoperoxidase 
staining pattern for the collagen 
III antibody observed within the 
FBR tumor.  (D) FBR collagen 
III  staining  pattern  at  higher 
magnification.  Note the marked 
staining  for collagen  III within 
the ECM of the FBR tumor. (E) 
G2A-R  control  collagen  III 
stain  at  the  tumor  periphery. 
Section  represents  the  back- 
ground  immunoperoxidase 
staining pattern for the collagen 
III antibody observed near the 
periphery of the G2A-R tumor. (F) Collagen III staining seen in the periphery of G2A-R tumors. Note the lack of enhanced collagen 
III staining at the periphery of G2A-R tumors compared to FBR tumors in B. Also note the overall decreased expression of collagen III 
throughout the G2A-R tumor. (G) G2A-R control collagen III stain at higher magnification. Section represents the background immu- 
noperoxidase staining pattern for the collagen III antibody observed within the G2A-R tumor. (H) G2A-R collagen III staining pattern 
at higher magnification. Note the lack of staining for collagen III in the G2A-R liposarcoma.  Compare this section with that of the FBR 
tumor in Fig. 9 D. Bars: (A, B, E, and F) 40 ~m; (C, D, G, and H) 10 I~m. 
lagen III expression pattern  (Abbott, D.,  and  J.T.  Holt, 
unpublished  data). Novel FBR transcriptional properties 
such as this may activate genes crucial to the disruption of 
specific cell lineage differentiation pathways. Such a phe- 
nomenon  is  mimicked  by  fibroblasts  treated  with  the 
DNA methylation inhibitor, 5-azacytidine (Chiang, 1981), 
which  enables  them  to  differentiate  into  chondrocytes, 
myocytes, and  adipocytes  (Sager and  Kovac, 1982).  Ab- 
sence  of  myristylation  may  eliminate  these  novel  FBR 
properties, restoring FBR's activity to that of its cellular 
homologue, c-Fos. 
Earlier data has demonstrated that the known molecu- 
lar mechanisms of c-Fos are restored in FBR v-los when 
its myristylation site is disrupted (Kamata and Holt, 1992; 
Kamata et al.,  1992;  Jotte et al.,  1994).  A  restoration  of 
transcriptional properties in G2A-R (so that it behaves as 
the  normal  cellular  Fos  protein)  may  allow  the  trans- 
formed cells to proceed down the differentiation pathway 
of the  adipocyte  lineage  and  leave  other  differentiation 
pathways  intact.  Many  studies  implicate  Fos  protein  as 
playing a role in modulating adipocyte differentiation-spe- 
cific gene expression (Distel et al., 1987;  Rauscher et al., 
1988; Herrera et al., 1989;  Barcellini-Couget et al., 1993). 
Fos sequences within FBR may allow transformed cells to 
proceed down the adipocyte lineage, and lack of myristyla- 
tion  prevents  FBR  from disrupting  multiple  differentia- 
tion pathways. 
Another striking myristylation-dependent feature is the 
malignant nature of the FBR tumors compared to that of 
the G2A-R tumors. Not only do a greater number of FBR 
transgenic  mice develop tumors,  but  they  also  die  from 
their  tumor burden.  This does  not  occur in  the  G2A-R 
transgenic mice. Myristylation endows FBR with a greater 
tumorigenic  and  malignant  potential  compared  to  non- 
myristylated G2A-R. This correlates with data  observed 
with c-Fos transgenic mice which present with benign tu- 
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picting sites of FBR and G2A-R 
disruption of cell-specific differ- 
entiation lineages. Diagram rep- 
resents  a  mechanism  by  which 
FBR may disrupt the differenti- 
ation pattern of multiple cell lin- 
eages.  Broken  lines  represent 
the points at which either FBR 
or G2A-R disrupt normal differ- 
entiation. Myristylated FBR dis- 
rupts  the  differentiation  path- 
ways  of  four  cell  lineages 
(adipocytes,  chondrocytes,  os- 
teocytes,  and  myocytes)  early, 
leading  to  malignant  tumors. 
When FBR  is  not  myristylated 
(G2A-R),  the  differentiation 
pathways  of  chondrocytes,  os- 
teocytes,  and myocytes proceed 
normally.  Nonmyristylated 
G2A-R still disrupts the differen- 
tiation pathway of the adipocyte, 
causing liposarcomas.  However, 
liposarcomas  are  a  tumor  of 
lesser malignant potential (com- 
pared  to  osteosarcomas,  chon- 
drosarcomas, and rhabdomyosar- 
comas). 
mors,  consisting primarily  of  differentiated 'bone-synthe- 
sizing  cells  (Rfither  et  al.,  1987).  More  importantly,  the 
large  number  of  primitive  mesenchymal  cells  and  ECM 
observed in the FBR  transgenic mouse tumors as well as in 
v-fos  retrovirus-induced  tumors  (Price  et  al.,  1972; Ward 
and Young, 1976) are absent in Fos and G2A-R  transgenic 
mouse  tumors  (Wagner  et al., 1987).  Surroundings rich in 
ECM  may  provide  the  proper  environment  essential  for 
the malignant nature of the FBR-induced  tumors. 
This  data  indicates  a  significant  in  vivo  role  of  FBR 
myristylation  that  dictates  the  disrupted  differentiation 
patterns of transformed  mesenchymal  cells. While the ex- 
act molecular mechanisms  of this alteration in differentia- 
tion remains unknown,  the in vivo transgenic data directly 
correlates with the observations of FBR  molecular mecha- 
nisms in vitro. Future  studies need to examine FBR's  mo- 
lecular properties that determine  differentiation to further 
define how transformed cells progress to tumor formation. 
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